フラクショナルレーザー機器を物理的なデバイスに、リポソームを化学的な器質に利用してドラッグデリバリーを行うという、僕の論文が注目を浴びているようで、今日も2社の英文雑誌からの次期論文の原稿依頼が来ました。
1つは痛みと麻酔についての国際誌、もう一つは薬剤導入傷害や代謝傷害による酸化ストレス障害についての専門誌です。
過去、薬学とレーザーがリンクした論文があまりなく、そういった意味でも注目されているのは嬉しい限りですね。
明日は京都の製薬企業での招待講演を頼まれており、朝から京都に向かう予定です。
台風で飛行機が飛ぶかなあ？
Dear Dr. Takahiro Fujimoto,
Warm Greetings from Scientia Ricerca!
Hope you are doing well!
We would like to write on behalf of Anaesthesia, Critical Care and Pain Management (ISSN: 2579-0188) journal based on your expertise and professionalism in the field of Anaesthesia.
We are honored to appreciate your excellence in the arena of Anaesthesia, especially your article entitled “Transcutaneous drug delivery by liposomes using fractional laser technology” is very interesting and quality articles like yours will definitely propel current research in the discipline of Anaesthesia.
We are delighted to welcome your precious article (Research/ Review/ Mini-Review/ Case Report/ Short Communication etc.) towards the upcoming issue of Anaesthesia, Critical Care and Pain Management (ACPM) Journal.
Please have a glance at the below link to view the latest articles
********************************
Dear Dr. Fujimoto,
We are currently accepting submissions for our upcoming Special Issue titled “Modulating Oxidative Stress in Drug-Induced Injury and Metabolic Disorders: The Role of Natural and Synthetic Antioxidants,” which will be published in Oxidative Medicine and Cellular Longevity in March 2019. The Special Issue is open to both original research articles and review articles, and the deadline for submission is October 19, 2018. You can find the Call for Papers at https://www.hindawi.com/journals/omcl/si/151845/cfp/.
The most recent Impact Factor for Oxidative Medicine and Cellular Longevity is 4.936 according to Clarivate Analytics’ latest Journal Citation Reports. The journal’s most recent CiteScore is 4.64 according to the latest CiteScore metrics released by Scopus. The journal is a peer-reviewed, open-access publication, which means that all published articles are made freely available online at https://www.hindawi.com/journals/omcl/ without a subscription and authors retain the copyright of their work. Moreover, all published articles will be made available on PubMed Central and indexed in PubMed at the time of publication.
Please read over the journal’s author guidelines at https://www.hindawi.com/journals/omcl/guidelines/ for more information on the journal’s policies and the submission process. Manuscripts should be submitted online to the Special Issue at https://mts.hindawi.com/submit/journals/omcl/moosdi/.
Please do not hesitate to contact me if you have any questions.
Best regards,
Amany Saad
